BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 24672652)

  • 1. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT).
    Allison JE; Fraser CG; Halloran SP; Young GP
    Gut Liver; 2014 Mar; 8(2):117-30. PubMed ID: 24672652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of fecal immunochemical tests for colorectal cancer screening.
    Daly JM; Bay CP; Levy BT
    J Prim Care Community Health; 2013 Oct; 4(4):245-50. PubMed ID: 23799674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Immunochemical Test: The World's Colorectal Cancer Screening Test.
    Robertson DJ; Selby K
    Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):511-526. PubMed ID: 32439085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FIT for the future: a case for risk-based colorectal cancer screening using the faecal immunochemical test.
    Cooper JA; Moss SM; Smith S; Seaman HE; Taylor-Phillips S; Parsons N; Halloran SP
    Colorectal Dis; 2016 Jul; 18(7):650-3. PubMed ID: 27135192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Robertson DJ; Lee JK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Lieberman D; Levin TR; Rex DK
    Gastroenterology; 2017 Apr; 152(5):1217-1237.e3. PubMed ID: 27769517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis : diagnostic accuracy of faecal immunochemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population.
    Stonestreet J; Chandrapalan S; Woolley D; Uthman U; Arasaradnam RP
    Acta Gastroenterol Belg; 2019; 82(2):291-299. PubMed ID: 31314191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative immunochemical fecal occult blood test for colorectal neoplasia.
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Ann Intern Med; 2007 Feb; 146(4):244-55. PubMed ID: 17310048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin.
    Fraser CG; Allison JE; Halloran SP; Young GP;
    J Natl Cancer Inst; 2012 Jun; 104(11):810-4. PubMed ID: 22472305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Robertson DJ; Lee JK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Lieberman D; Levin TR; Rex DK
    Am J Gastroenterol; 2017 Jan; 112(1):37-53. PubMed ID: 27753435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase.
    Caviglia GP; Cabianca L; Fagoonee S; Gili FM
    Biochem Med (Zagreb); 2016; 26(1):114-20. PubMed ID: 26981025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which Fecal Immunochemical Test Should I Choose?
    Daly JM; Xu Y; Levy BT
    J Prim Care Community Health; 2017 Oct; 8(4):264-277. PubMed ID: 28447866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program.
    Chiang TH; Chuang SL; Chen SL; Chiu HM; Yen AM; Chiu SY; Fann JC; Chou CK; Lee YC; Wu MS; Chen HH
    Gastroenterology; 2014 Dec; 147(6):1317-26. PubMed ID: 25200099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.
    Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR
    Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
    Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
    Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
    Malagón M; Ramió-Pujol S; Serrano M; Amoedo J; Oliver L; Bahí A; Miquel-Cusachs JO; Ramirez M; Queralt-Moles X; Gilabert P; Saló J; Guardiola J; Piñol V; Serra-Pagès M; Castells A; Aldeguer X; Garcia-Gil LJ
    PLoS One; 2020; 15(12):e0243158. PubMed ID: 33259546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative immunochemical fecal occult blood tests: is it time to go back to the future?
    Imperiale TF
    Ann Intern Med; 2007 Feb; 146(4):309-11. PubMed ID: 17310056
    [No Abstract]   [Full Text] [Related]  

  • 19. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
    Tinmouth J; Lansdorp-Vogelaar I; Allison JE
    Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden.
    Petersen MM; Kleif J; Jørgensen LN; Hendel JW; Seidelin JB; Madsen MR; Vilandt J; Brandsborg S; Rasmussen JS; Andersen LM; Khalid A; Ferm L; Gawel SH; Martens F; Andersen B; Rasmussen M; Davis GJ; Christensen IJ; Therkildsen C
    Clin Colorectal Cancer; 2023 Jun; 22(2):199-210. PubMed ID: 36878807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.